CRI Clinic and Laboratory Integration Program (CLIP)
Cancer Research Institute (CRI) · Nonprofit
Source: Cancer Research Institute (CRI) (curated) · View original posting ↗
Open two-stage cycle (verified 2026-07-31): LOI deadline December 1, 2026; invited full proposals due March 12, 2027. Invitations issued by the end of January. Deadlines falling on a weekend roll to the following Monday; applications due 11:59pm Eastern.
- AwardWhat a single award can be worth — the funder's published per-award amount or floor–ceiling range.
- Up to $300K
- DeadlineFinal application due date.
- Mar 12, 2027
- Letter of intentDue date for the letter of intent (a short pre-application some funders require or request before the full proposal).
- Dec 1, 2026
- MechanismNIH activity code — the grant type (R01 research project, R21 exploratory, K series career development, F series fellowship, …).
- —
- DurationMaximum project period for a single award.
- 2 yr
- Expected awardsHow many awards the funder anticipates making under this opportunity.
- —
- Funding cycleHow often the program accepts applications (annual, multiple cycles per year, rolling, or one-time).
- Recurring (annual)
- Open dateWhen applications open (or opened).
- —
- Total fundingThe overall pool the funder expects to commit across ALL awards under this opportunity — not what one project receives.
- $300K total
- Clinical trialWhether proposed projects must, may, or must not include a clinical trial.
- Optional / allowed
Research areas
Auto-classified from the title and description (keyword-based) — may be imperfect.
Description
Translational grants ($300,000 over two years, renewable once to $600,000) funding immuno-oncology research that directly informs or emerges from clinical practice. Curated entry; verify current terms at the program page.
This funder has no public API, so the entry is manually curated — confirm current amounts, deadlines, and eligibility on the source page.